Lowering the burden of Ebola

In response to the Ebola epidemic in West Africa, the Horizon 2020 EU research initiative ‘EVIDENT’ was launched in November 2014. Equipped with a budget of € 1.7 million, the two-year EVIDENT project provided a research platform which built upon the success of the European Mobile Laboratory consortium (EMLab) that was performing Ebola Virus Disease (EVD) diagnostics in affected West African countries since March 2014. EVIDENT’s mandate was to scientifically exploit specimens from EVD patients collected as part of the outbreak response in Guinea, Liberia and Sierra Leone and to gather critical knowledge on B and T cell immunology, biomarkers, virus evolution, virulence determinants, and transmission of Ebola Virus.

An overview of the project results is available here and in the EVIDENT summary.